The promise of scientific and medical innovation often comes with a downside: improvements in care benefit some people, but not all. Without concerted effort, that is exactly what could happen with ...

Physicians at the University of Chicago Medicine are increasing their use of liquid biopsies, an emerging technology that detects signs of cancerous tumors with a simple blood test rather than an ...

This is read by an automated voice. Please report any issues or inconsistencies here. Next-generation sequencing commands the market by enabling the simultaneous profiling of multiple genetic ...

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early detection plays a crucial role in reducing cancer-related morbidity and ...

Liquid biopsies—tests that detect circulating tumor cellular components in the bloodstream—have the potential to transform cancer by reducing health inequities in screening, diagnostics, and ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early detection plays a crucial role in reducing cancer-related morbidity and ...

Please provide your email address to receive an email when new articles are posted on . Liquid biopsy identified CAR T cells with superior sensitivity compared with traditional DNA testing. Liquid ...

—Canio Martinelli, MD, Director of Clinical and Translational Research, Sbarro Health Research Organization at Temple University in Philadelphia, discusses this rapidly evolving field. Liquid biopsy ...